In an industrial collaboration project, TU Wien has developed a medication that can alleviate or even completely eliminate the symptoms of celiac disease. It should be available as early as 2021.
Celiac disease is a fairly common disease, affecting one to two percent of the European population. It is expressed as a hypersensitivity to gluten, a protein found in cereals such as wheat, barley or rye.
Although efforts are already being made to treat celiac disease, the proposed drugs have an effect on the immune system. Possible side effects must therefore be examined very carefully. Although initial clinical studies are underway, they will not lead to a marketable product in the next few years.
For this reason, an entirely different approach has been pursued at TU Wien in collaboration with the industrial partner Sciotech Diagnostic Technologies GmbH. Instead of developing a drug that interferes with the immune system, TU Wien has created a simple medical product that directly attacks the gluten molecules to render them harmless. This makes the approval process much simpler, meaning that the product should be available in ordinary pharmacies as early as 2021.
Molecules like keys and locks
“Our bodies produce antibodies that fit intruding antigens precisely, like a key to a lock. This immune response makes these antigens harmless,” explains Professor Oliver Spadiut, head of the Integrated Bioprocess Development Research Group at TU Wien. “If a new antibody fragment is found and produced that docks to and blocks the invading gluten molecule without triggering the immune system, the symptoms of celiac disease can be suppressed.”
The aim of the research project was therefore to produce a complex of two such antibody fragments that envelop the gluten molecule at a molecular level, so that it can no longer have any further effects in the intestines.
To do this, certain bacteria have to be reprogrammed so that they produce exactly the desired antibody fragment. “The formation of such proteins in a bacterium is a highly complicated process,” explains Oliver Spadiut. “It can easily happen that the proteins are not folded exactly as we want.” Instead of the desired antibody fragments, so-called “inclusion bodies” are formed – small particles consisting of incorrectly folded proteins. A process therefore had to be developed to refold these inclusion bodies and to obtain the desired proteins from them.
Such processes, in which the folding of proteins is specifically altered, have not yet been studied in great detail and so they are not very efficient. “You have to precisely understand the chemical processes involved and intervene in a complicated way,” says Oliver Spadiut. “It has therefore taken a while, but we have now developed a process that can be easily reproduced, can be scaled up to industrial application and delivers a very good yield of the desired product”
In pharmacies soon
The project was supported by the industrial partner SCIOTEC Diagnostic Technologies GmbH, who will now bring the new medical product to the market. “It will be a preparation that celiac patients can take together with gluten-containing foods to alleviate coeliac symptoms,” explains Oliver Spadiut. “It remains to be seen whether the symptoms will disappear completely or will only be alleviated. The precise effects will probably vary from person to person.
Learn more: A new remedy for celiac disease
The Latest on: Celiac disease
via Google News
The Latest on: Celiac disease
- Nursing home staff lag in COVID-19 vaccinations; Celiac disease does not boost COVID-19 riskson February 24, 2021 at 3:07 pm
Residents of nursing homes are among the most vulnerable to severe COVID-19, but vaccinations appear to be lagging among staff members who care for them, US Centers for Disease Control and Prevention ...
- Democrats Must Stop the IRS From Eating the Unemployed’s Stimulus Checkson February 24, 2021 at 1:13 pm
If Biden doesn’t forgive the taxes on millions of Americans’ unemployment benefits, they might not forgive him for their giant surprise tax bills.
- Renowned Nutrition Expert Puts Rare Disease Day on the Radaron February 24, 2021 at 7:12 am
To raise awareness of Rare Disease Day on February 28, Envara Health founder and nutrition expert Virginia A. Stallings, M.D., highlights the nutritional challenges and therapies for people living ...
- High abundance of sugar metabolisers in saliva of children with carieson February 24, 2021 at 3:19 am
Abstract Dental caries is a biofilm-mediated, dynamic disease with early onset. A balanced salivary microbiota is a foundation of oral health, while dysbiosis causes tooth decay. We compared the ...
- Anokion Appoints Deborah Geraghty, Ph.D., as President and Chief Executive Officeron February 23, 2021 at 10:30 am
Anokion SA, a Swiss biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance, today announced that Deborah Ge ...
- Do gluten-free diets provide a cure-all for celiac disease?on February 23, 2021 at 10:18 am
A new study provides insights into the curative effects of gluten-free diets in celiac patients. Results from the proteomics-based research suggests not.
- 40 in 40: Casey Sadleron February 23, 2021 at 2:00 am
If you only want to read about Casey Sadler’s baseball work, please skip down to the starred portion below. In 1938, Dorothy Hansine Andersen, a pediatrician and pathologist at the ...
- Type 1 Diabetes With Celiac Disease Increases Depression Risk in Adolescentson February 19, 2021 at 8:34 am
Adolescent boys and girls with type 1 diabetes (T1D) and celiac disease (CD) have an increased risk for depression, highlighting the importance of depression screenings as part of routine care, ...
- Celiac Disease Foundation Advocates Urge Congress To Continue Support of Celiac Disease Research Fundingon February 18, 2021 at 8:00 am
Celiac disease afflicts millions of Americans, most of whom are undiagnosed, and is second only to end-stage renal disease in perceived ...
via Bing News